Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation programme
Prioritisation programme
HealthTech (4)
Medicines evaluation (3)
None selected (372)
Decision
Decision
Awaiting decision (51)
Further information required (26)
Not selected (298)
Apply filters
Showing 41 to 50 of 379
Sort by
Decision date
Title
Apply sorting
Topic prioritisation
Title
Prioritisation programme
Decision
Decision date
Zanubrutinib for Chronic lymphocytic leukaemia (CLL) or Follicular lymphoma or Marginal zone lymphoma (MZL) or Waldenstrom's macroglobulinaemia [ID12199]
None selected
Not selected
16 June 2025
Lutetium (177Lu) oxodotreotide for treating SSTR-positive advanced or inoperable gastroenteropancreatic neuroendocrine tumours in people 12 to 17 years [TSID12154]
None selected
Not selected
16 June 2025
Risankizumab for treating moderate to severe plaque psoriasis in people 6 to 17 years [TSID12204]
None selected
Not selected
16 June 2025
Excimer Laser Trabeculotomy (ELT) for glaucoma
None selected
Awaiting decision
29 May 2025
Percutaneous nephrolithotomy for kidney stones greater than 1.5cm
None selected
Not selected
29 May 2025
Epicranial focal cortex stimulation for drug-resistant focal epilepsy
None selected
Not selected
29 May 2025
Diltiazem (Anatop, SLV-324, VEN 307) for Anal fissure [TSID 12100]
None selected
Not selected
16 May 2025
Mosunetuzumab for treating relapsed or refractory follicular lymphoma [TSID 12081]
None selected
Not selected
16 May 2025
Nifedipine - Lidocaine for Chronic Anal Fissure [TSID 12093]
None selected
Not selected
16 May 2025
Subcutaneous nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over [TSID 12178]
None selected
Not selected
16 May 2025
Previous page
1
…
3
4
Current page
5
6
7
…
38
Page
5
of
38
Next page
Results per page
10
25
50
All
Back to top